uva-dare (digital academic repository) anti-inflammatory ... · arabadzisz d, antal k, parpan f,...
TRANSCRIPT
UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Anti-inflammatory strategies during epileptogenesis
Holtman, L.
Link to publication
Citation for published version (APA):Holtman, L. (2013). Anti-inflammatory strategies during epileptogenesis.
General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).
Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.
Download date: 05 Jan 2021
References
189
References
Adams B, Von Ling E, Vaccarella L, Ivy GO, Fahnestock M, Racine RJ. (1998) Time course for kindling‐induced changes in the hilar area of the dentate gyrus: reactive gliosis as a potential mechanism. Brain Res 804:331‐336.
Alapirtti T, Rinta S, Hulkkonen J, Makinen R, Keranen T, Peltola J. (2009) Interleukin‐6, interleukin‐1 receptor antagonist and interleukin‐1beta production in patients with focal epilepsy: A video‐EEG study. J Neurol Sci 280:94‐97.
Alexander JJ, Anderson AJ, Barnum SR, Stevens B, Tenner AJ. (2008) The complement cascade: Yin‐Yang in neuroinflammation‐‐neuro‐protection and ‐degeneration. J Neurochem 107:1169‐1187.
Allan SM, Rothwell NJ. (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734‐744.
Arabadzisz D, Antal K, Parpan F, Emri Z, Fritschy JM. (2005) Epileptogenesis and chronic seizures in a mouse model of temporal lobe epilepsy are associated with distinct EEG patterns and selective neurochemical alterations in the contralateral hippocampus. Exp Neurol 194:76‐90.
Aronica E, Boer K, van Vliet EA, Redeker S, Baayen JC, Spliet WG, van Rijen PC, Troost D, da Silva FH, Wadman WJ, Gorter JA. (2007) Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26:497‐511.
Aronica E, Crino PB. (2011) Inflammation in epilepsy: clinical observations. Epilepsia 52 Suppl 3:26‐32.
Aronica E, Ravizza T, Zurolo E, Vezzani A. (2012) Astrocyte immune responses in epilepsy. Glia:n/a‐n/a.
Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP, Taylor SM. (2009) Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 158:1074‐1089.
References
190
Auvin S, Mazarati A, Shin D, Sankar R. (2010a) Inflammation enhances epileptogenesis in the developing rat brain. Neurobiol Dis 40:303‐310.
Auvin S, Porta N, Nehlig A, Lecointe C, Vallee L, Bordet R. (2009) Inflammation in rat pups subjected to short hyperthermic seizures enhances brain long‐term excitability. Epilepsy Res 86:124‐130.
Auvin S, Shin D, Mazarati A, Sankar R. (2010b) Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 51 Suppl 3:34‐38.
Avnir Y, Ulmansky R, Wasserman V, Even‐Chen S, Broyer M, Barenholz Y, Naparstek Y. (2008) Amphipathic weak acid glucocorticoid prodrugs remote‐loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis. Arthritis Rheum 58:119‐129.
Baik EJ, Kim EJ, Lee SH, Moon C. (1999) Cyclooxygenase‐2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res 843:118‐129.
Balosso S, Maroso M, Sanchez‐Alavez M, Ravizza T, Frasca A, Bartfai T, Vezzani A. (2008) A novel non‐transcriptional pathway mediates the proconvulsive effects of interleukin‐1beta. Brain 131:3256‐3265.
Banks WA, Erickson MA. (2010) The blood‐brain barrier and immune function and dysfunction. Neurobiol Dis 37:26‐32.
Barnes PJ. (2011) Glucocorticosteroids: current and future directions. Br J Pharmacol 163:29‐43.
Bauer B, Hartz AM, Pekcec A, Toellner K, Miller DS, Potschka H. (2008) Seizure‐induced up‐regulation of P‐glycoprotein at the blood‐brain barrier through glutamate and cyclooxygenase‐2 signaling. Mol Pharmacol 73:1444‐1453.
References
191
Bauer S, Cepok S, Todorova‐Rudolph A, Nowak M, Koller M, Lorenz R, Oertel WH, Rosenow F, Hemmer B, Hamer HM. (2009) Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res 86:82‐88.
Beghi E. (2003) Overview of studies to prevent posttraumatic epilepsy. Epilepsia 44 Suppl 10:21‐26.
Bellander BM, Singhrao SK, Ohlsson M, Mattsson P, Svensson M. (2001) Complement activation in the human brain after traumatic head injury. J Neurotrauma 18:1295‐1311.
Bengzon J, Kokaia Z, Elmer E, Nanobashvili A, Kokaia M, Lindvall O. (1997) Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 94:10432‐10437.
Bengzon J, Mohapel P, Ekdahl CT, Lindvall O. (2002) Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res 135:111‐119.
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005‐2009. Epilepsia 51:676‐685.
Bertram E. (2007) The relevance of kindling for human epilepsy. Epilepsia 48 Suppl 2:65‐74.
Bezzi P, Carmignoto G, Pasti L, Vesce S, Rossi D, Rizzini BL, Pozzan T, Volterra A. (1998) Prostaglandins stimulate calcium‐dependent glutamate release in astrocytes. Nature 391:281‐285.
Bhole D, Stahl GL. (2004) Molecular basis for complement component 6 (C6) deficiency in rats and mice. Immunobiology 209:559‐568.
Bialer M, White HS. (2010) Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov 9:68‐82.
References
192
Biber K, Sauter A, Brouwer N, Copray SC, Boddeke HW. (2001) Ischemia‐induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid‐tissue Chemokine (SLC). Glia 34:121‐133.
Biber K, Zuurman MW, Dijkstra IM, Boddeke HW. (2002) Chemokines in the brain: neuroimmunology and beyond. Curr Opin Pharmacol 2:63‐68.
Block ML, Zecca L, Hong JS. (2007) Microglia‐mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57‐69.
Bonifati DM, Kishore U. (2007) Role of complement in neurodegeneration and neuroinflammation. Mol Immunol 44:999‐1010.
Bonow RH, Aid S, Zhang Y, Becker KG, Bosetti F. (2009) The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice. Pharmacogenomics J 9:116‐126.
Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, Le Gal La Salle G. (1999) Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89:717‐729.
Brodie MJ, Shorvon SD, Canger R, Halasz P, Johannessen S, Thompson P, Wieser HG, Wolf P. (1997) Commission on European Affairs: appropriate standards of epilepsy care across Europe.ILEA. Epilepsia 38:1245‐1250.
Buckingham SE, Chervoneva I, Sharan A, Zangaladze A, Mintzer S, Skidmore C, Nei M, Evans J, Pequignot E, Sperling MR. (2010) Latency to first seizure after temporal lobectomy predicts long‐term outcome. Epilepsia 51:1987‐1993.
Buckmaster PS. (2004) Laboratory animal models of temporal lobe epilepsy. Comp Med 54:473‐485.
References
193
Buckmaster PS, Lew FH. (2011) Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. J Neurosci 31:2337‐2347.
Cavazos JE, Cross DJ. (2006) The role of synaptic reorganization in mesial temporal lobe epilepsy. Epilepsy Behav 8:483‐493.
Cavazos JE, Das I, Sutula TP. (1994) Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J Neurosci 14:3106‐3121.
Cavazos JE, Golarai G, Sutula TP. (1991) Mossy fiber synaptic reorganization induced by kindling: time course of development, progression, and permanence. J Neurosci 11:2795‐2803.
Cavazos JE, Golarai G, Sutula TP. (1992) Septotemporal variation of the supragranular projection of the mossy fiber pathway in the dentate gyrus of normal and kindled rats. Hippocampus 2:363‐372.
Chan WY, Kohsaka S, Rezaie P. (2007) The origin and cell lineage of microglia: new concepts. Brain Res Rev 53:344‐354.
Chen C, Bazan NG. (2005) Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 93:929‐941.
Chen J, Marsh T, Zhang JS, Graham SH. (1995) Expression of cyclo‐oxygenase 2 in rat brain following kainate treatment. Neuroreport 6:245‐248.
Cho J, Nelson TE, Bajova H, Gruol DL. (2009) Chronic CXCL10 alters neuronal properties in rat hippocampal culture. J Neuroimmunol 207:92‐100.
Choi J, Min HJ, Shin JS. (2011) Increased levels of HMGB1 and pro‐inflammatory cytokines in children with febrile seizures. J Neuroinflammation 8:135.
References
194
Christensen J, Pedersen MG, Pedersen CB, Sidenius P, Olsen J, Vestergaard M. (2009) Long‐term risk of epilepsy after traumatic brain injury in children and young adults: a population‐based cohort study. Lancet 373:1105‐1110.
Chu Y, Jin X, Parada I, Pesic A, Stevens B, Barres B, Prince DA. (2010) Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc Natl Acad Sci U S A 107:7975‐7980.
Cole DS, Morgan BP. (2003) Beyond lysis: how complement influences cell fate. Clin Sci (Lond) 104:455‐466.
Coutinho AE, Chapman KE. (2011) The anti‐inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335:2‐13.
Darke K, Edwards SW, Hancock E, Johnson AL, Kennedy CR, Lux AL, Newton RW, O'Callaghan FJ, Verity CM, Osborne JP. (2010) Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi‐centre randomised trial. Arch Dis Child 95:382‐386.
de Boer AG, Gaillard PJ. (2007) Drug targeting to the brain. Annu Rev Pharmacol Toxicol 47:323‐355.
de Jong EK, de Haas AH, Brouwer N, van Weering HR, Hensens M, Bechmann I, Pratley P, Wesseling E, Boddeke HW, Biber K. (2008) Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. J Neurochem 105:1726‐1736.
De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, De Luigi A, Garattini S, Vezzani A. (2000) Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 12:2623‐2633.
De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L. (2004) The powerful neuroprotective action of C1‐inhibitor on brain
References
195
ischemia‐reperfusion injury does not require C1q. Am J Pathol 164:1857‐1863.
Deprez F, Zattoni M, Mura ML, Frei K, Fritschy JM. (2011) Adoptive transfer of T lymphocytes in immunodeficient mice influences epileptogenesis and neurodegeneration in a model of temporal lobe epilepsy. Neurobiol Dis 44:174‐184.
Desjardins P, Sauvageau A, Bouthillier A, Navarro D, Hazell AS, Rose C, Butterworth RF. (2003) Induction of astrocytic cyclooxygenase‐2 in epileptic patients with hippocampal sclerosis. Neurochem Int 42:299‐303.
deToledo J, Ramsay RE, Marsan CA. (1996) The lunatic and his seizure. Neurology 47:292‐293.
Dhir A, Akula KK, Kulkarni SK. (2008) Rofecoxib potentiates the anticonvulsant effect of topiramate. Inflammopharmacology 16:83‐86.
Dube C, Vezzani A, Behrens M, Bartfai T, Baram TZ. (2005) Interleukin‐1beta contributes to the generation of experimental febrile seizures. Ann Neurol 57:152‐155.
Dube CM, Brewster AL, Baram TZ. (2009) Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev 31:366‐371.
Dube CM, Ravizza T, Hamamura M, Zha Q, Keebaugh A, Fok K, Andres AL, Nalcioglu O, Obenaus A, Vezzani A, Baram TZ. (2010) Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 30:7484‐7494.
Dudek FE, Staley KJ. (2011) The time course of acquired epilepsy: implications for therapeutic intervention to suppress epileptogenesis. Neurosci Lett 497:240‐246.
Dudek FE, Sutula TP. (2007) Epileptogenesis in the dentate gyrus: a critical perspective. Prog Brain Res 163:755‐773.
References
196
Eid T, Williamson A, Lee TS, Petroff OA, de Lanerolle NC. (2008) Glutamate and astrocytes‐‐key players in human mesial temporal lobe epilepsy? Epilepsia 49 Suppl 2:42‐52.
Engel J, Jr. (1996) Clinical evidence for the progressive nature of epilepsy. Epilepsy Res Suppl 12:9‐20.
Engel J, Jr., Wilson C, Bragin A. (2003) Advances in understanding the process of epileptogenesis based on patient material: what can the patient tell us? Epilepsia 44 Suppl 12:60‐71.
Evans MC, Stolp HB, Gaillard PJ, De Boer M, Appeldoorn CC, Dorland R, Sibson R, Turner MR, Anthony DC. (2012) CNS‐targeted anti‐inflammatory agent reduces pathology in mouse model of ALS. 15th symposium Signal Transduction in Blood‐Brain Barriers, Berlin.
Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, Bach S, Angiari S, Benati D, Chakir A, Zanetti L, Schio F, Osculati A, Marzola P, Nicolato E, Homeister JW, Xia L, Lowe JB, McEver RP, Osculati F, Sbarbati A, Butcher EC, Constantin G. (2008) A role for leukocyte‐endothelial adhesion mechanisms in epilepsy. Nat Med 14:1377‐1383.
Francis K, van Beek J, Canova C, Neal JW, Gasque P. (2003) Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med 5:1‐19.
Friedman A, Kaufer D, Heinemann U. (2009) Blood‐brain barrier breakdown‐inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 85:142‐149.
Gaillard PJ. (2010) Crossing barriers from blood‐to‐brain and academia‐to‐industry. Therapeutic Delivery 1:495‐500.
Gaillard PJ, Appeldoorn CC, Rip J, Dorland R, van der Pol SM, Kooij G, de Vries HE, Reijerkerk A. (2012) Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release.
References
197
Gaillard PJ, Visser CC, Appeldoorn CCM, Rip J. (2011) Enhanced brain drug delivery: safely crossing the blood‐brain barrier. Drug Discovery Today: Technologies.
Galanopoulou AS, Gorter JA, Cepeda C. (2012) Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia 53:1119‐1130.
Galic MA, Riazi K, Pittman QJ. (2012) Cytokines and brain excitability. Front Neuroendocrinol 33:116‐125.
Gasque P, Dean YD, McGreal EP, VanBeek J, Morgan BP. (2000) Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49:171‐186.
Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140:918‐934.
Gobbo OL, O'Mara SM. (2004) Post‐treatment, but not pre‐treatment, with the selective cyclooxygenase‐2 inhibitor celecoxib markedly enhances functional recovery from kainic acid‐induced neurodegeneration. Neuroscience 125:317‐327.
Goddard GV, McIntyre DC, Leech CK. (1969) A permanent change in brain function resulting from daily electrical stimulation. Exp Neurol 25:295‐330.
Goldberg SH, van der Meer P, Hesselgesser J, Jaffer S, Kolson DL, Albright AV, Gonzalez‐Scarano F, Lavi E. (2001) CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27:127‐138.
Gorter JA, Goncalves Pereira PM, van Vliet EA, Aronica E, Lopes da Silva FH, Lucassen PJ. (2003) Neuronal cell death in a rat model for mesial temporal lobe epilepsy is induced by the initial status epilepticus and not by later repeated spontaneous seizures. Epilepsia 44:647‐658.
References
198
Gorter JA, Mesquita AR, van Vliet EA, da Silva FH, Aronica E. (2005) Increased expression of ferritin, an iron‐storage protein, in specific regions of the parahippocampal cortex of epileptic rats. Epilepsia 46:1371‐1379.
Gorter JA, van Vliet EA, Aronica E, Breit T, Rauwerda H, Lopes da Silva FH, Wadman WJ. (2006) Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. J Neurosci 26:11083‐11110.
Gorter JA, van Vliet EA, Aronica E, Lopes da Silva FH. (2001) Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin‐immunoreactive neurons. Eur J Neurosci 13:657‐669.
Gorter JA, Van Vliet EA, Rauwerda H, Breit T, Stad R, van Schaik L, Vreugdenhil E, Redeker S, Hendriksen E, Aronica E, Lopes da Silva FH, Wadman WJ. (2007) Dynamic changes of proteases and protease inhibitors revealed by microarray analysis in CA3 and entorhinal cortex during epileptogenesis in the rat. Epilepsia 48 Suppl 5:53‐64.
Goverman J. (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393‐407.
Govoni S, Masoero E, Favalli L, Rozza A, Scelsi R, Viappiani S, Buccellati C, Sala A, Folco G. (2001) The Cycloxygenase‐2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat. Neurosci Lett 303:91‐94.
Groom JR, Luster AD. (2011) CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89:207‐215.
Gupta R, Appleton R. (2005) Corticosteroids in the management of the paediatric epilepsies. Arch Dis Child 90:379‐384.
Hailer NP. (2008) Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84:211‐233.
References
199
Hewett SJ, Silakova JM, Hewett JA. (2006) Oral treatment with rofecoxib reduces hippocampal excitotoxic neurodegeneration. J Pharmacol Exp Ther 319:1219‐1224.
Holtkamp M, Matzen J, van Landeghem F, Buchheim K, Meierkord H. (2005) Transient loss of inhibition precedes spontaneous seizures after experimental status epilepticus. Neurobiol Dis 19:162‐170.
Holtman L, van Vliet EA, van Schaik R, Queiroz CM, Aronica E, Gorter JA. (2009) Effects of SC58236, a selective COX‐2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res 84:56‐66.
Hoozemans JJ, Rozemuller AJ, Janssen I, De Groot CJ, Veerhuis R, Eikelenboom P. (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol 101:2‐8.
Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME. (2001) Reduced susceptibility to ischemic brain injury and N‐methyl‐D‐aspartate‐mediated neurotoxicity in cyclooxygenase‐2‐deficient mice. Proc Natl Acad Sci U S A 98:1294‐1299.
Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O, Seiffert E, Heinemann U, Friedman A. (2007) TGF‐beta receptor‐mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 130:535‐547.
Jabs R, Seifert G, Steinhauser C. (2008) Astrocytic function and its alteration in the epileptic brain. Epilepsia 49 Suppl 2:3‐12.
Jacoby A, Austin JK. (2007) Social stigma for adults and children with epilepsy. Epilepsia 48 Suppl 9:6‐9.
Jakubs K, Bonde S, Iosif RE, Ekdahl CT, Kokaia Z, Kokaia M, Lindvall O. (2008) Inflammation regulates functional integration of neurons born in adult brain. J Neurosci 28:12477‐12488.
References
200
Jamali S, Bartolomei F, Robaglia‐Schlupp A, Massacrier A, Peragut JC, Regis J, Dufour H, Ravid R, Roll P, Pereira S, Royer B, Roeckel‐Trevisiol N, Fontaine M, Guye M, Boucraut J, Chauvel P, Cau P, Szepetowski P. (2006) Large‐scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129:625‐641.
Jamali S, Salzmann A, Perroud N, Ponsole‐Lenfant M, Cillario J, Roll P, Roeckel‐Trevisiol N, Crespel A, Balzar J, Schlachter K, Gruber‐Sedlmayr U, Pataraia E, Baumgartner C, Zimprich A, Zimprich F, Malafosse A, Szepetowski P. (2010) Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizures. PLoS One 5.
Joseph SA, Lynd‐Balta E, O'Banion MK, Rappold PM, Daschner J, Allen A, Padowski J. (2006) Enhanced cyclooxygenase‐2 expression in olfactory‐limbic forebrain following kainate‐induced seizures. Neuroscience 140:1051‐1065.
Jung KH, Chu K, Lee ST, Kim J, Sinn DI, Kim JM, Park DK, Lee JJ, Kim SU, Kim M, Lee SK, Roh JK. (2006) Cyclooxygenase‐2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine‐induced status epilepticus. Neurobiol Dis 23:237‐246.
Kamm K, Vanderkolk W, Lawrence C, Jonker M, Davis AT. (2006) The effect of traumatic brain injury upon the concentration and expression of interleukin‐1beta and interleukin‐10 in the rat. J Trauma 60:152‐157.
Karst H, de Kloet ER, Joels M. (1999) Episodic corticosterone treatment accelerates kindling epileptogenesis and triggers long‐term changes in hippocampal CA1 cells, in the fully kindled state. Eur J Neurosci 11:889‐898.
Kawaguchi K, Hickey RW, Rose ME, Zhu L, Chen J, Graham SH. (2005) Cyclooxygenase‐2 expression is induced in rat brain after kainate‐induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res 1050:130‐137.
References
201
Kelley KA, Ho L, Winger D, Freire‐Moar J, Borelli CB, Aisen PS, Pasinetti GM. (1999) Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase‐2. Am J Pathol 155:995‐1004.
Khurgel M, Ivy GO. (1996) Astrocytes in kindling: relevance to epileptogenesis. Epilepsy Res 26:163‐175.
Kienzler F, Norwood BA, Sloviter RS. (2009) Hippocampal injury, atrophy, synaptic reorganization, and epileptogenesis after perforant pathway stimulation‐induced status epilepticus in the mouse. J Comp Neurol 515:181‐196.
Kim HJ, Chung JI, Lee SH, Jung YS, Moon CH, Baik EJ. (2008) Involvement of endogenous prostaglandin F2alpha on kainic acid‐induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX‐2 inhibitors. Brain Res 1193:153‐161.
Kobayashi M, Wen X, Buckmaster PS. (2003) Reduced inhibition and increased output of layer II neurons in the medial entorhinal cortex in a model of temporal lobe epilepsy. J Neurosci 23:8471‐8479.
Kunz T, Oliw EH. (2001) The selective cyclooxygenase‐2 inhibitor rofecoxib reduces kainate‐induced cell death in the rat hippocampus. Eur J Neurosci 13:569‐575.
Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314‐319.
Kwon CS, Liu M, Quan H, Wiebe S, McChesney J, Wirrell E, Hamiwka L, Jette N. (2010) The incidence of injuries in persons with and without epilepsy‐‐a population‐based study. Epilepsia 51:2247‐2253.
Lee B, Dziema H, Lee KH, Choi YS, Obrietan K. (2007) CRE‐mediated transcription and COX‐2 expression in the pilocarpine model of status epilepticus. Neurobiol Dis 25:80‐91.
References
202
Leenaerts PL, Stad RK, Hall BM, Van Damme BJ, Vanrenterghem Y, Daha MR. (1994) Hereditary C6 deficiency in a strain of PVG/c rats. Clin Exp Immunol 97:478‐482.
Lehnardt S. (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll‐like receptor‐mediated neuronal injury. Glia 58:253‐263.
Lehtimaki KA, Keranen T, Huhtala H, Hurme M, Ollikainen J, Honkaniemi J, Palmio J, Peltola J. (2004) Regulation of IL‐6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration. J Neuroimmunol 152:121‐125.
Lehtimaki KA, Keranen T, Palmio J, Makinen R, Hurme M, Honkaniemi J, Peltola J. (2007) Increased plasma levels of cytokines after seizures in localization‐related epilepsy. Acta Neurol Scand 116:226‐230.
Lehtimaki KA, Liimatainen S, Peltola J, Arvio M. (2011) The serum level of interleukin‐6 in patients with intellectual disability and refractory epilepsy. Epilepsy Res 95:184‐187.
Leinhase I, Holers VM, Thurman JM, Harhausen D, Schmidt OI, Pietzcker M, Taha ME, Rittirsch D, Huber‐Lang M, Smith WR, Ward PA, Stahel PF. (2006) Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci 7:55.
Leinhase I, Rozanski M, Harhausen D, Thurman JM, Schmidt OI, Hossini AM, Taha ME, Rittirsch D, Ward PA, Holers VM, Ertel W, Stahel PF. (2007) Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti‐factor B antibody: a randomized placebo‐controlled study in mice. J Neuroinflammation 4:13.
Libbey JE, Kirkman NJ, Wilcox KS, White HS, Fujinami RS. (2010) Role for complement in the development of seizures following acute viral infection. J Virol 84:6452‐6460.
References
203
Liimatainen S, Fallah M, Kharazmi E, Peltola M, Peltola J. (2009) Interleukin‐6 levels are increased in temporal lobe epilepsy but not in extra‐temporal lobe epilepsy. J Neurol 256:796‐802.
Linker RA, Weller C, Luhder F, Mohr A, Schmidt J, Knauth M, Metselaar JM, Gold R. (2008) Liposomal glucocorticosteroids in treatment of chronic autoimmune demyelination: long‐term protective effects and enhanced efficacy of methylprednisolone formulations. Exp Neurol 211:397‐406.
Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM. (2006) Severe disease, unaltered leukocyte migration, and reduced IFN‐gamma production in CXCR3‐/‐ mice with experimental autoimmune encephalomyelitis. J Immunol 176:4399‐4409.
Loane DJ, Byrnes KR. (2010) Role of microglia in neurotrauma. Neurotherapeutics 7:366‐377.
Longhi L, Perego C, Ortolano F, Zanier ER, Bianchi P, Stocchetti N, McIntosh TK, De Simoni MG. (2009) C1‐inhibitor attenuates neurobehavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit Care Med 37:659‐665.
Longo BM, Mello LE. (1997) Blockade of pilocarpine‐ or kainate‐induced mossy fiber sprouting by cycloheximide does not prevent subsequent epileptogenesis in rats. Neurosci Lett 226:163‐166.
Lopes da Silva FH, Kamphuis W, Titulaer M, Vreugdenhil M, Wadman WJ. (1995) An experimental model of progressive epilepsy: the development of kindling of the hippocampus of the rat. Ital J Neurol Sci 16:45‐57.
Loscher W, Brandt C. (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668‐700.
Lothman EW, Bertram EH, Kapur J, Stringer JL. (1990) Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res 6:110‐118.
References
204
Mackay CR. (2001) Chemokines: immunology's high impact factors. Nat Immunol 2:95‐101.
Magiorkinis E, Sidiropoulou K, Diamantis A. (2010) Hallmarks in the history of epilepsy: epilepsy in antiquity. Epilepsy Behav 17:103‐108.
Mann MW. (2010) The epileptic seizure and the mystery of death in Christian painting. Epilepsy Behav 17:139‐146.
Marchi N, Fan Q, Ghosh C, Fazio V, Bertolini F, Betto G, Batra A, Carlton E, Najm I, Granata T, Janigro D. (2009) Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 33:171‐181.
Marchi N, Granata T, Freri E, Ciusani E, Ragona F, Puvenna V, Teng Q, Alexopolous A, Janigro D. (2011a) Efficacy of anti‐inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 6:e18200.
Marchi N, Johnson AJ, Puvenna V, Johnson HL, Tierney W, Ghosh C, Cucullo L, Fabene PF, Janigro D. (2011b) Modulation of peripheral cytotoxic cells and ictogenesis in a model of seizures. Epilepsia.
Marchi N, Oby E, Batra A, Uva L, De Curtis M, Hernandez N, Van Boxel‐Dezaire A, Najm I, Janigro D. (2007) In vivo and in vitro effects of pilocarpine: relevance to ictogenesis. Epilepsia 48:1934‐1946.
Marchi N, Tierney W, Alexopoulos AV, Puvenna V, Granata T, Janigro D. (2011c) The etiological role of blood‐brain barrier dysfunction in seizure disorders. Cardiovasc Psychiatry Neurol 2011:482415.
Maroso M, Balosso S, Ravizza T, Iori V, Wright CI, French J, Vezzani A. (2011a) Interleukin‐1beta biosynthesis inhibition reduces acute seizures and drug resistant chronic epileptic activity in mice. Neurotherapeutics 8:304‐315.
Maroso M, Balosso S, Ravizza T, Liu J, Aronica E, Iyer AM, Rossetti C, Molteni M, Casalgrandi M, Manfredi AA, Bianchi ME, Vezzani A. (2011b)
References
205
Toll‐like receptor 4 and high‐mobility group box‐1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 16:413‐419.
Mathern GW, Babb TL, Leite JP, Pretorius K, Yeoman KM, Kuhlman PA. (1996) The pathogenic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res 26:151‐161.
Mazarati A, Bragin A, Baldwin R, Shin D, Wilson C, Sankar R, Naylor D, Engel J, Wasterlain CG. (2002) Epileptogenesis after self‐sustaining status epilepticus. Epilepsia 43 Suppl 5:74‐80.
Mazarati AM, Wasterlain CG, Sankar R, Shin D. (1998) Self‐sustaining status epilepticus after brief electrical stimulation of the perforant path. Brain Res 801:251‐253.
McCombe PA, Henderson RD. (2011) The role of immune and inflammatory mechanisms in ALS. Curr Mol Med 11:246‐254.
McIntyre DC, Poulter MO, Gilby K. (2002) Kindling: some old and some new. Epilepsy Res 50:79‐92.
McKhann GM, 2nd, Wenzel HJ, Robbins CA, Sosunov AA, Schwartzkroin PA. (2003) Mouse strain differences in kainic acid sensitivity, seizure behavior, mortality, and hippocampal pathology. Neuroscience 122:551‐561.
McMaster A, Ray DW. (2007) Modelling the glucocorticoid receptor and producing therapeutic agents with anti‐inflammatory effects but reduced side‐effects. Exp Physiol 92:299‐309.
Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 95:14500‐14505.
Minghetti L. (2004) Cyclooxygenase‐2 (COX‐2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63:901‐910.
References
206
Morimoto K, Fahnestock M, Racine RJ. (2004) Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol 73:1‐60.
Motti D, Le Duigou C, Eugene E, Chemaly N, Wittner L, Lazarevic D, Krmac H, Marstrand T, Valen E, Sanges R, Stupka E, Sandelin A, Cherubini E, Gustincich S, Miles R. (2010) Gene expression analysis of the emergence of epileptiform activity after focal injection of kainic acid into mouse hippocampus. Eur J Neurosci 32:1364‐1379.
Muller M, Carter SL, Hofer MJ, Manders P, Getts DR, Getts MT, Dreykluft A, Lu B, Gerard C, King NJ, Campbell IL. (2007) CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol 179:2774‐2786.
Neligan A, Bell GS, Shorvon SD, Sander JW. (2010) Temporal trends in the mortality of people with epilepsy: a review. Epilepsia 51:2241‐2246.
Nelson TE, Gruol DL. (2004) The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J Neuroimmunol 156:74‐87.
Neumann H, Kotter MR, Franklin RJ. (2009) Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132:288‐295.
Nimmerjahn A, Kirchhoff F, Helmchen F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314‐1318.
Oliveira MS, Furian AF, Royes LF, Fighera MR, Fiorenza NG, Castelli M, Machado P, Bohrer D, Veiga M, Ferreira J, Cavalheiro EA, Mello CF. (2008) Cyclooxygenase‐2/PGE2 pathway facilitates pentylenetetrazol‐induced seizures. Epilepsy Res 79:14‐21.
References
207
Osawa M, Uemura S, Kimura H, Sato M. (2001) Amygdala kindling develops without mossy fiber sprouting and hippocampal neuronal degeneration in rats. Psychiatry Clin Neurosci 55:549‐557.
Ottman R, Lipton RB, Ettinger AB, Cramer JA, Reed ML, Morrison A, Wan GJ. (2011) Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 52:308‐315.
Ozkara C, Vigevano F. (2011) Immuno‐ and antiinflammatory therapies in epileptic disorders. Epilepsia 52 Suppl 3:45‐51.
Parent JM, Kron MM. (2012) Neurogenesis and Epilepsy. In Noebels JL AM, Rogawski MA, et al., editors, (Ed) Jasper's basic mechanisms of the epilepsies (internet). Center for Biotechnology Information (US), Bethesda (MD).
Paxinos G. (1995) The rat nervous system. Academic Press, San Diego ; London.
Paxinos G, Franklin KBJ. (2008) The Mouse Brain in Stereotaxic Coordinates, Compact, 3rd Edition. Academic Press.
Paxinos G, Watson C. (1998) The rat brain in stereotaxic coordinates, San Diego.
Pedersen BK, Febbraio MA. (2008) Muscle as an endocrine organ: focus on muscle‐derived interleukin‐6. Physiol Rev 88:1379‐1406.
Pekcec A, Fuest C, Muhlenhoff M, Gerardy‐Schahn R, Potschka H. (2008) Targeting epileptogenesis‐associated induction of neurogenesis by enzymatic depolysialylation of NCAM counteracts spatial learning dysfunction but fails to impact epilepsy development. J Neurochem 105:389‐400.
Pekcec A, Lupke M, Baumann R, Seifert H, Potschka H. (2011) Modulation of neurogenesis by targeted hippocampal irradiation fails to affect kindling progression. Hippocampus 21:866‐876.
References
208
Pekcec A, Unkruer B, Schlichtiger J, Soerensen J, Hartz AM, Bauer B, van Vliet EA, Gorter JA, Potschka H. (2009) Targeting prostaglandin E2 EP1 receptors prevents seizure‐associated P‐glycoprotein up‐regulation. J Pharmacol Exp Ther 330:939‐947.
Peltola J, Laaksonen J, Haapala AM, Hurme M, Rainesalo S, Keranen T. (2002) Indicators of inflammation after recent tonic‐clonic epileptic seizures correlate with plasma interleukin‐6 levels. Seizure 11:44‐46.
Peltola J, Palmio J, Korhonen L, Suhonen J, Miettinen A, Hurme M, Lindholm D, Keranen T. (2000) Interleukin‐6 and interleukin‐1 receptor antagonist in cerebrospinal fluid from patients with recent tonic‐clonic seizures. Epilepsy Res 41:205‐211.
Pepys MB, Hirschfield GM. (2003) C‐reactive protein: a critical update. J Clin Invest 111:1805‐1812.
Perry VH, Cunningham C, Holmes C. (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7:161‐167.
Pitkanen A. (2010) Therapeutic approaches to epileptogenesis‐‐hope on the horizon. Epilepsia 51 Suppl 3:2‐17.
Pitkanen A, Kharatishvili I, Narkilahti S, Lukasiuk K, Nissinen J. (2005) Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat. Epilepsy Res 63:27‐42.
Pitkanen A, Lukasiuk K. (2009) Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 14 Suppl 1:16‐25.
Pitkanen A, Lukasiuk K. (2011) Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 10:173‐186.
Pitkanen A, Narkilahti S, Bezvenyuk Z, Haapalinna A, Nissinen J. (2004) Atipamezole, an alpha(2)‐adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res 61:119‐140.
References
209
Pitkanen A, Nissinen J, Nairismagi J, Lukasiuk K, Grohn OH, Miettinen R, Kauppinen R. (2002) Progression of neuronal damage after status epilepticus and during spontaneous seizures in a rat model of temporal lobe epilepsy. Prog Brain Res 135:67‐83.
Pitkänen A, Schwartzkroin PA, Moshé SL. (2006) Models of seizures and epilepsy. Elsevier Academic, Amsterdam ; Oxford.
Plata‐Salaman CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, Kelly ME, Bureau Y, Anisman H, McIntyre DC. (2000) Kindling modulates the IL‐1beta system, TNF‐alpha, TGF‐beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res 75:248‐258.
Polazzi E, Monti B. (2010) Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog Neurobiol 92:293‐315.
Prync AE, Arzt E, Fernandez Castelo S, Finkielman S, Nahmod V. (1992) The inhibitory effect of the muscarinic agonist pilocarpine on lymphocyte activation involves the IL‐2 pathway and the increase in suppressor cell function. Int J Neurosci 62:277‐285.
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55:453‐462.
Racine RJ. (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281‐294.
Racine RJ, Steingart M, Bureau Y, McIntyre DC. (2003) Differential sensitivity of genetically Fast vs. Slow kindling rats strains to GABAergic convulsive agents. Neuropharmacology 45:918‐924.
Raedt R, Boon P, Persson A, Alborn AM, Boterberg T, Van Dycke A, Linder B, De Smedt T, Wadman WJ, Ben‐Menachem E, Eriksson PS. (2007) Radiation of the rat brain suppresses seizure‐induced neurogenesis and transiently enhances excitability during kindling acquisition. Epilepsia 48:1952‐1963.
References
210
Ralay Ranaivo H, Wainwright MS. (2010) Albumin activates astrocytes and microglia through mitogen‐activated protein kinase pathways. Brain Res 1313:222‐231.
Ramaglia V, King RH, Nourallah M, Wolterman R, de Jonge R, Ramkema M, Vigar MA, van der Wetering S, Morgan BP, Troost D, Baas F. (2007) The membrane attack complex of the complement system is essential for rapid Wallerian degeneration. J Neurosci 27:7663‐7672.
Ransohoff RM, Kivisakk P, Kidd G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3:569‐581.
Ransohoff RM, Perry VH. (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119‐145.
Rappert A, Bechmann I, Pivneva T, Mahlo J, Biber K, Nolte C, Kovac AD, Gerard C, Boddeke HW, Nitsch R, Kettenmann H. (2004) CXCR3‐dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24:8500‐8509.
Rappert A, Biber K, Nolte C, Lipp M, Schubel A, Lu B, Gerard NP, Gerard C, Boddeke HW, Kettenmann H. (2002) Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl‐ current and chemotaxis in murine microglia. J Immunol 168:3221‐3226.
Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. (2008a) Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 29:142‐160.
Ravizza T, Lucas SM, Balosso S, Bernardino L, Ku G, Noe F, Malva J, Randle JC, Allan S, Vezzani A. (2006) Inactivation of caspase‐1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 47:1160‐1168.
Ravizza T, Noe F, Zardoni D, Vaghi V, Sifringer M, Vezzani A. (2008b) Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis
References
211
in rats by blocking astrocytic IL‐1beta production. Neurobiol Dis 31:327‐333.
Ravizza T, Rizzi M, Perego C, Richichi C, Veliskova J, Moshe SL, De Simoni MG, Vezzani A. (2005) Inflammatory response and glia activation in developing rat hippocampus after status epilepticus. Epilepsia 46 Suppl 5:113‐117.
Ravizza T, Vezzani A. (2006) Status epilepticus induces time‐dependent neuronal and astrocytic expression of interleukin‐1 receptor type I in the rat limbic system. Neuroscience 137:301‐308.
Riazi K, Galic MA, Kuzmiski JB, Ho W, Sharkey KA, Pittman QJ. (2008) Microglial activation and TNFalpha production mediate altered CNS excitability following peripheral inflammation. Proc Natl Acad Sci U S A 105:17151‐17156.
Riazi K, Galic MA, Pittman QJ. (2010) Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 89:34‐42.
Riban V, Bouilleret V, Pham‐Le BT, Fritschy JM, Marescaux C, Depaulis A. (2002) Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112:101‐111.
Rip J, Chen L, van Kregten J, Dorland R, van der Boom B, C. A, de Boer M, Gaillard PJ. (2011) In vitro evaluation and optimization of drug delivery from glutathione‐conjugated PEG coated liposomes. 9th International Conference on Cerebral Vascular Biology, Leiden.
Rivest S. (2009) Regulation of innate immune responses in the brain. Nat Rev Immunol 9:429‐439.
Ros‐Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L, Alvarez‐Fischer D, Carrillo‐de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, Hoglinger G, Hamon M, Tronche F, Hirsch EC, Vyas S. (2011)
References
212
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci U S A 108:6632‐6637.
Rus H, Cudrici C, David S, Niculescu F. (2006) The complement system in central nervous system diseases. Autoimmunity 39:395‐402.
Sandhya TL, Ong WY, Horrocks LA, Farooqui AA. (1998) A light and electron microscopic study of cytoplasmic phospholipase A2 and cyclooxygenase‐2 in the hippocampus after kainate lesions. Brain Res 788:223‐231.
Sayin U, Osting S, Hagen J, Rutecki P, Sutula T. (2003) Spontaneous seizures and loss of axo‐axonic and axo‐somatic inhibition induced by repeated brief seizures in kindled rats. J Neurosci 23:2759‐2768.
Scharfman HE, Gray WP. (2007) Relevance of seizure‐induced neurogenesis in animal models of epilepsy to the etiology of temporal lobe epilepsy. Epilepsia 48 Suppl 2:33‐41.
Schauwecker PE. (2002) Modulation of cell death by mouse genotype: differential vulnerability to excitatory amino acid‐induced lesions. Exp Neurol 178:219‐235.
Schauwecker PE, Steward O. (1997) Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci U S A 94:4103‐4108.
Scheiermann P, Hoegl S, Hofstetter C, Pfeilschifter J, Zwissler B, Muhl H, Boost KA, Scheller B. (2011) Comparing hemodynamics, blood gas analyses and proinflammatory cytokines in endotoxemic and severely septic rats. Int Immunopharmacol 11:719‐723.
Seifert G, Schilling K, Steinhauser C. (2006) Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 7:194‐206.
References
213
Sevilla‐Castillo RA, Palacios GC, Ramirez‐Campos J, Mora‐Puga M, Diaz‐Bustos R. (2009) Methylprednisolone for the treatment of children with refractory epilepsy. Neuropediatrics 40:265‐268.
Shorvon S, Ferlisi M. (2011) The treatment of super‐refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 134:2802‐2818.
Simmons DL, Botting RM, Hla T. (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387‐437.
Sloviter RS. (1982) A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res Bull 8:771‐774.
Sloviter RS. (2008) Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts. Epilepsia 49 Suppl 9:85‐92.
Sørensen TL. (2004) Targeting the Chemokine Receptor CXCR3 and Its Ligand CXCL10 in the Central Nervous System: Potential Therapy for Inflammatory Demyelinating Disease? Current Neurovascular Research 1:183‐190.
Stellwagen D, Beattie EC, Seo JY, Malenka RC. (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor‐alpha. J Neurosci 25:3219‐3228.
Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA. (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131:1164‐1178.
Storini C, Rossi E, Marrella V, Distaso M, Veerhuis R, Vergani C, Bergamaschini L, De Simoni MG. (2005) C1‐inhibitor protects against brain
References
214
ischemia‐reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis 19:10‐17.
Sutula TP, Dudek FE. (2007) Unmasking recurrent excitation generated by mossy fiber sprouting in the epileptic dentate gyrus: an emergent property of a complex system. Prog Brain Res 163:541‐563.
Sutula TP, Hermann B. (1999) Progression in mesial temporal lobe epilepsy. Ann Neurol 45:553‐556.
Sutula TP, Ockuly J. (2006) Kindling, spontaneous seizures, and the consequences of epilepsy: more than a model. In Pitkanen A, Schwartzkroin PA, Moshé SL, (Eds) Models of seizures and epilepsy. Elsevier Academic Press.
Takemiya T, Suzuki K, Sugiura H, Yasuda S, Yamagata K, Kawakami Y, Maru E. (2003) Inducible brain COX‐2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat 71:205‐216.
Temkin NR. (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta‐analysis of controlled trials. Epilepsia 42:515‐524.
Temkin NR. (2003) Risk factors for posttraumatic seizures in adults. Epilepsia 44 Suppl 10:18‐20.
Temkin NR. (2009) Preventing and treating posttraumatic seizures: the human experience. Epilepsia 50 Suppl 2:10‐13.
Temkin O. (1945) The falling sickness. The John Hopkins University Press, Baltimore.
Thom M, Eriksson S, Martinian L, Caboclo LO, McEvoy AW, Duncan JS, Sisodiya SM. (2009) Temporal lobe sclerosis associated with hippocampal sclerosis in temporal lobe epilepsy: neuropathological features. J Neuropathol Exp Neurol 68:928‐938.
References
215
Thom M, Mathern GW, Cross JH, Bertram EH. (2010) Mesial temporal lobe epilepsy: How do we improve surgical outcome? Ann Neurol 68:424‐434.
Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang J, Nedergaard M. (2005) An astrocytic basis of epilepsy. Nat Med 11:973‐981.
Tischner D, Reichardt HM. (2007) Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol 275:62‐70.
Tomoum HY, Badawy NM, Mostafa AA, Harb MY. (2007) Plasma interleukin‐1beta levels in children with febrile seizures. J Child Neurol 22:689‐692.
Tu B, Bazan NG. (2003) Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase‐2 expression in neocortex. Exp Neurol 179:167‐175.
Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, Licata G. (2009) Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 9:1240‐1260.
van Beek J, Elward K, Gasque P. (2003) Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann N Y Acad Sci 992:56‐71.
van Dixhoorn MG, Timmerman JJ, Van Gijlswijk‐Janssen DJ, Muizert Y, Verweij C, Discipio RG, Daha MR. (1997) Characterization of complement C6 deficiency in a PVG/c rat strain. Clin Exp Immunol 109:387‐396.
van Gassen KL, de Wit M, Koerkamp MJ, Rensen MG, van Rijen PC, Holstege FC, Lindhout D, de Graan PN. (2008) Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49:1055‐1065.
van Vliet EA, Aronica E, Tolner EA, Lopes da Silva FH, Gorter JA. (2004) Progression of temporal lobe epilepsy in the rat is associated with
References
216
immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp Neurol 187:367‐379.
van Vliet EA, da Costa Araujo S, Redeker S, van Schaik R, Aronica E, Gorter JA. (2007a) Blood‐brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 130:521‐534.
van Vliet EA, Forte G, Holtman L, den Burger JC, Sinjewel A, de Vries HE, Aronica E, Gorter JA. (2012) Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood‐brain barrier leakage but not microglia activation. Epilepsia 53:1254‐1263.
van Vliet EA, van Schaik R, Edelbroek PM, da Silva FH, Wadman WJ, Gorter JA. (2008) Development of tolerance to levetiracetam in rats with chronic epilepsy. Epilepsia 49:1151‐1159.
van Vliet EA, van Schaik R, Edelbroek PM, Redeker S, Aronica E, Wadman WJ, Marchi N, Vezzani A, Gorter JA. (2006) Inhibition of the multidrug transporter P‐glycoprotein improves seizure control in phenytoin‐treated chronic epileptic rats. Epilepsia 47:672‐680.
van Vliet EA, van Schaik R, Edelbroek PM, Voskuyl RA, Redeker S, Aronica E, Wadman WJ, Gorter JA. (2007b) Region‐specific overexpression of P‐glycoprotein at the blood‐brain barrier affects brain uptake of phenytoin in epileptic rats. J Pharmacol Exp Ther 322:141‐147.
van Vliet EA, Zibell G, Pekcec A, Schlichtiger J, Edelbroek PM, Holtman L, Aronica E, Gorter JA, Potschka H. (2010) COX‐2 inhibition controls P‐glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats. Neuropharmacology 58:404‐412.
van Weering HR, Boddeke HW, Vinet J, Brouwer N, de Haas AH, van Rooijen N, Thomsen AR, Biber KP. (2010a) CXCL10/CXCR3 signaling in glia cells differentially affects NMDA‐induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus.
References
217
van Weering HR, de Jong AP, de Haas AH, Biber KP, Boddeke HW. (2010b) CCL21‐induced calcium transients and proliferation in primary mouse astrocytes: CXCR3‐dependent and independent responses. Brain Behav Immun 24:768‐775.
Vazquez Caruncho M, Branas Fernandez F. (2011) The hallucinations of Frederic Chopin. Med Humanit 37:5‐8.
Velisek L, Moshe SL. (2003) Temporal lobe epileptogenesis and epilepsy in the developing brain: bridging the gap between the laboratory and the clinic. Progression, but in what direction? Epilepsia 44 Suppl 12:51‐59.
Vezzani A. (2005) Inflammation and epilepsy. Epilepsy Curr 5:1‐6.
Vezzani A, Aronica E, Mazarati A, Pittman QJ. (2011a) Epilepsy and brain inflammation. Experimental Neurology.
Vezzani A, Bartfai T, Bianchi M, Rossetti C, French J. (2011b) Therapeutic potential of new antiinflammatory drugs. Epilepsia 52 Suppl 8:67‐69.
Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG. (1999) Interleukin‐1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 19:5054‐5065.
Vezzani A, French J, Bartfai T, Baram TZ. (2011c) The role of inflammation in epilepsy. Nat Rev Neurol 7:31‐40.
Vezzani A, Granata T. (2005) Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 46:1724‐1743.
Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. (2011d) IL‐1 receptor/Toll‐like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 25:1281‐1289.
References
218
Vezzani A, Ravizza T, Balosso S, Aronica E. (2008) Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 49 Suppl 2:24‐32.
Virta M, Hurme M, Helminen M. (2002) Increased plasma levels of pro‐ and anti‐inflammatory cytokines in patients with febrile seizures. Epilepsia 43:920‐923.
Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. (2003) Interleukin‐1beta enhances NMDA receptor‐mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692‐8700.
Viviani B, Gardoni F, Marinovich M. (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247‐263.
Voutsinos‐Porche B, Koning E, Kaplan H, Ferrandon A, Guenounou M, Nehlig A, Motte J. (2004) Temporal patterns of the cerebral inflammatory response in the rat lithium‐pilocarpine model of temporal lobe epilepsy. Neurobiol Dis 17:385‐402.
Wiedmer T, Sims PJ. (1985) Effect of complement proteins C5b‐9 on blood platelets. Evidence for reversible depolarization of membrane potential. J Biol Chem 260:8014‐8019.
Xiong ZQ, Qian W, Suzuki K, McNamara JO. (2003) Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 23:955‐960.
Xu B, McIntyre DC, Fahnestock M, Racine RJ. (2004) Strain differences affect the induction of status epilepticus and seizure‐induced morphological changes. Eur J Neurosci 20:403‐418.
Yu JX, Bradt BM, Cooper NR. (2002) Constitutive expression of proinflammatory complement components by subsets of neurons in the central nervous system. J Neuroimmunol 123:91‐101.
References
219
Zattoni M, Mura ML, Deprez F, Schwendener RA, Engelhardt B, Frei K, Fritschy JM. (2011) Brain infiltration of leukocytes contributes to the pathophysiology of temporal lobe epilepsy. J Neurosci 31:4037‐4050.
Zibell G, Unkruer B, Pekcec A, Hartz AM, Bauer B, Miller DS, Potschka H. (2009) Prevention of seizure‐induced up‐regulation of endothelial P‐glycoprotein by COX‐2 inhibition. Neuropharmacology 56:849‐855.
Zlotnik A, Yoshie O. (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121‐127.